Adaptive RadioTherapy for OroPharynx Cancer

Clinical trial NCT04901234 · RECRUITING

Trial details

NCT number: NCT04901234
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharynx Cancer Radiotherapy; Complications Radiotherapy Side Effect Dysphagia MRI

Start date: 2021-07-30
Primary completion: 2024-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.